Skip to content

Clinical trials

Active, not recruiting Observational Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Status: Active, not recruiting Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20062
20083
20091
20102
20114
20122
20133
20142
20157
20162
20171
20184
20196
20205
20219
20225
202312
202414
202510
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting120

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)5
Abramson Cancer Center at Penn Medicine3
Herlev and Gentofte Hospital3
AstraZeneca2
Brigham and Women's Hospital2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Imperial College London2
Institut National de la Santé Et de la Recherche Médicale, France2
Institut für Pharmakologie und Präventive Medizin2
John Sievenpiper2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases120
Heart Diseases25
Coronary Disease18
Diabetes Mellitus17
Hypertension16
Heart Failure14
Stroke14
Atherosclerosis12
Coronary Artery Disease12
Obesity10

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.